High 30-day mortality rates in advanced cancer patients receiving checkpoint inhibitors show there is still a need for careful selection of patients for treatment, Australian researchers have shown. Traditional chemotherapy has been associated with 30-day mortality rates of 8-18% in patients with advanced cancers and it had been hoped the more favourable side effect profile ...
Lung Cancer
Careful patient selection needed to avoid high early mortality with immunotherapy
By Michael Woodhead
3 Jun 2019